Pharmagen ApS
CVR 36687193 · Private limited company (ApS) · Active · Medium risk
Pharmagen ApS is a Private limited company (ApS), founded on , based in Gentofte. The company is registered in the industry fremstilling af farmaceutiske præparater. Our model estimates a bankruptcy risk of 1.4% over the next 12 months, which is 1.0 times the average for Danish companies. 11 annual reports have been published. The latest annual report (30 Sep 2025) shows equity of DKK -275k and a net result of DKK 36k. CEO: Mads Juul Hedegaard.
Bankruptcy risk for Pharmagen ApS
1.0 × the average (1.41%) · higher risk than 77% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 36687193
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (11 years)
- Address
- Grusbakken 2D
2820 Gentofte - Municipality
- Gentofte
- Industry
- Fremstilling af farmaceutiske præparater (212000)
Bankruptcies in the industry: Fremstilling af farmaceutiske præparater - Share capital
- DKK 50k
- Auditor
- Revision Sjælland Godkendt Revisionsaktieselskab
- Audit opted out
- Yes
Warning signs
| Annual reports filed late | 0 of 11 |
| Missing annual report | No |
| Negative equity | Yes |
| Equity ratio | -28.3% |
| Current ratio | 39% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 2 |
| CEO's previous bankruptcies | 1 |
| Other companies at the address | 17 |
| Going-concern uncertainty | Yes |
Financials and key figures
| Financial year | 2025 | 2024 |
|---|---|---|
| Gross profit | DKK -16k | DKK -14k |
| Net profit | DKK 36k | DKK -19k |
| Equity | DKK -275k | DKK -311k |
| Total assets | DKK 973k | DKK 933k |
| Cash | DKK 130k | – |
| Short-term debt | DKK 1.2m | – |
| Avg. employees | 0 | – |
Latest annual report: Reporting class B · auditor's statement: Andre erklæringer uden sikkerhed · Revision Sjælland Godkendt Revisionsaktieselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Oct 2024 – 30 Sep 2025 | 106 | ||
| 1 Oct 2023 – 30 Sep 2024 | 30 | ||
| 1 Oct 2022 – 30 Sep 2023 | 41 | ||
| 1 Oct 2021 – 30 Sep 2022 | 68 | ||
| 1 Oct 2020 – 30 Sep 2021 | 78 | ||
| 1 Oct 2019 – 30 Sep 2020 | 70 | ||
| 1 Oct 2018 – 30 Sep 2019 | 81 | ||
| 1 Oct 2017 – 30 Sep 2018 | 150 | ||
| 1 Oct 2016 – 30 Sep 2017 | 152 | ||
| 1 Oct 2015 – 30 Sep 2016 | 181 | ||
| 18 Mar 2015 – 30 Sep 2015 | 75 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Mads Juul Hedegaard | Current | |
| CEO | Hans-Ole Hedegaard | ||
| Owner (100%) | Hans-Ole Hedegaard | Current | |
| Auditor | Grant Thornton, Godkendt Revisionspartnerselskab | ||
| Auditor | REVISION SJÆLLAND GODKENDT REVISIONSAKTIESELSKAB | ||
| Founder | Hans-Ole Hedegaard | Current |
The CEOs' other companies
Mads Juul Hedegaard – 1 other companies
- MEDI-TRADE ApS Active
Hans-Ole Hedegaard – 6 other companies, of which 1 bankrupt
- ELDONCARD A/S Bankrupt 18 Jul 2002
- Dana Genetic A/S Opløst
- ELDON BIOLOGICALS A/S Active
- HENOL KEMI ApS, KLÆBESTOFFER OG MASKINER Compulsorily dissolved
- KAPITALFORMIDLINGSSELSKABET AF 12.3.1996 A/S Opløst
- MEDI-TRADE ApS Active
Address history (1 moves)
| Grusbakken 2D, 2820 Gentofte | |
| c/o Hans-Ole Hedegaard, Søllerød Park 19, 1. 18, 2840 Holte |
Other companies at the same address
- ERIK BJØRKHOLT A/S Bankrupt
- LA LUMIéRE ApS Bankrupt
- LIMOTEX ApS Bankrupt
- MALERFIRMAET WILS ApS Bankrupt
- Ren-Byg Service ApS Bankrupt
- A Blinkenberg Holding ApS Active
- Blinkenbros Holding ApS Fusioneret
- Dana Genetic A/S Opløst
- E Blinkenberg Holding ApS Active
- Gentofte Tømrer & Byg ApS Active
- MEDI-TRADE ApS Active
- Rosenfeldt Fotografi ApS Active
- Rosenfeldt Studios ApS Opløst
- SLEJPNER A/S Active
- SLEJPNER HOLDING ApS Active
- SLEJPNER PLASTTEKNIK ApS Opløst
- W. SVANEMOSE A/S Fusioneret
Similar companies in Gentofte
- SamGo Pharma ApS Hellerup
- NEUROINNOVATECH ApS Klampenborg
- Cessatech A/S Hellerup
- TLACPH Consulting ApS Charlottenlund
- Cordane ApS Hellerup
- Vanquish Innovation ApS Charlottenlund
- Xtherapeutics ApS Charlottenlund
- VetInject A/S Hellerup
- AKTIESELSKABET AF 1. JUNI 2011 I Hellerup
- Ascendis Pharma Growth Disorders A/S Hellerup
- ASCENDIS PHARMA BONE DISEASES A/S Hellerup
- ASCENDIS PHARMA, OPHTHALMOLOGY DIVISION A/S Hellerup
Questions and answers about Pharmagen ApS
Has Pharmagen ApS gone bankrupt?
No, Pharmagen ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Pharmagen ApS?
Our model estimates a bankruptcy risk of 1.4% over the next 12 months (medium risk), which is 1.0 times the average for Danish companies.
Who is the CEO of Pharmagen ApS?
Mads Juul Hedegaard is the CEO of Pharmagen ApS.
Who is the auditor of Pharmagen ApS?
Pharmagen ApS most recently used Revision Sjælland Godkendt Revisionsaktieselskab.
When was Pharmagen ApS founded?
Pharmagen ApS was founded on 18 March 2015.
What is the equity of Pharmagen ApS?
Equity was DKK -275k according to the annual report for the period ending 30 September 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.